Home Newsfeeds SVB Financial Deposit Outflows Outpacing Sale Process – Sources

News

SVB Financial Deposit Outflows Outpacing Sale Process – Sources

– CNBC

byHappy Mohamed

March 10, 2023

1 minute read

– CNBC

SELLAS Life Sciences Announces Positive Recommendation From REGAL Independent Data Monitoring Committee Of Galinpepimut-S In Acute Myeloid Leukemia

By Benzinga Newsdesk

December 4, 9:47 AM

- Independent Data Monitoring Committee (IDMC) Recommended Continuation of Phase 3 REGAL Trial Without Any Modifications -- IDMC Expressed Satisfaction with Speed of Enrollment and High Study Integrity -- IDMC Will

SLS

Kinnate Biopharma Receives Fast Track Designation From The U.S. FDA For KIN-2787, An Investigational Pan-RAF Inhibitor

By Benzinga Newsdesk

September 21, 4:07 PM

SAN FRANCISCO and SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (NASDAQ:KNTE) ("Kinnate"), a clinical-stage precision oncology company, today announced that the U.S. Food and Drug

KNTE

Natural Grocers Q1 EPS $0.19 Misses $0.23 Estimate, Sales $280.46M Beat $270.00M Estimate

By Michael Horton

February 2, 5:20 PM

Natural Grocers (NYSE:NGVC) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.23 by 17.39 percent. This is a 51.28 percent decrease over earnings of $0.39 per share from the

NGVC

No Recession In 2024? Institutional Investors Long On Magnificent 7, Small Caps

By Neil Dennis

January 16, 9:25 AM

Investors are confident about no recession in 2024, preferring tech giants, overweight on US equities, and expect Fed rate cuts and corporate earnings.

AAPL

SVB Financial Deposit Outflows Outpacing Sale Process – Sources

Related Posts

SELLAS Life Sciences Announces Positive Recommendation From REGAL Independent Data Monitoring Committee Of Galinpepimut-S In Acute Myeloid Leukemia

Kinnate Biopharma Receives Fast Track Designation From The U.S. FDA For KIN-2787, An Investigational Pan-RAF Inhibitor

Natural Grocers Q1 EPS $0.19 Misses $0.23 Estimate, Sales $280.46M Beat $270.00M Estimate

No Recession In 2024? Institutional Investors Long On Magnificent 7, Small Caps